equity dilution

Advertisement

cGxPJobs Banner

Moleculin Secures $6.8M to Support Clinical Development Plans

HOUSTON, Texas, Dec. 10, 2025 — Moleculin Biotech, a clinical-stage company developing novel oncology drug candidates including Annamycin for...

By cGxPwire Editor
December 11, 2025

Read More

Advertisement

cGxPJobs

Directory